# A Study of Multiple Doses of Lasmiditan in Healthy Participants

> **NCT03252015** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 70 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Probe Drug Cocktail
- **DRUG:** Lasmiditan
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03252015
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-08-15
- **Primary completion:** 2018-01-02
- **Final completion:** 2018-01-02
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2020-01-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03252015

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03252015, "A Study of Multiple Doses of Lasmiditan in Healthy Participants". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03252015. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*